Understanding survival differences in ovarian cancer among Asian Americans
Official title: Examining the disparities in ovarian cancer survival among Asian Americans
Funded at California State University Fullerton · NIH-10907504 · Data updated 2026-11-12
This study looks at how different groups of Asian American women with ovarian cancer are doing, focusing on their unique experiences and survival rates, to better understand the differences in their cancer types and outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California State University Fullerton NIH-funded |
| Lab location | 1 site (Fullerton, United States) |
| Project start | September 22, 2021 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $17,290 |
| NIH project number | 5P20CA253251-04 |
| Project ID | NIH-10907504 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Asian American women diagnosed with ovarian cancer.
✕Less likely to help
Patients who do not identify as Asian American or those with other types of cancer may not receive benefit from this research.
What this research studies
This research investigates the survival rates of ovarian cancer among Asian American women, recognizing that this population is not homogenous. By utilizing data from the California Cancer Registry, the project aims to identify ethnic-specific disparities in tumor characteristics and survival outcomes. The study will analyze how different Asian subethnic groups may experience varying grades, stages, and types of ovarian cancer, which could influence their survival rates. This approach seeks to provide a more nuanced understanding of ovarian cancer survival among diverse Asian American communities.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and tailored interventions for ovarian cancer patients from different Asian subethnic backgrounds.
How similar studies have gone: Previous research has indicated that analyzing ethnic-specific disparities can reveal important insights, suggesting that this approach may yield valuable findings.
Where this research is happening
-
California State University Fullerton
Fullerton, United States Active
Researchers
- Principal investigator: Lee, Alice — California State University Fullerton
- Study coordinator: Lee, Alice
Related research
Other NIH-funded projects on the same topics.
-
Understanding the experience of ovarian cancer after diagnosis to improve survivorship
This NIH grant funds a mixed-methods study to better understand physical and emotional challenges faced by ovarian cancer survivors and how supportive care can help them live better after diagnosis.
-
Targeting quiescent ovarian cancer cells to overcome chemotherapy resistance
A study focusing on why some ovarian cancer cells pause dividing and resist chemotherapy, with the goal of finding new treatment targets for relapsed disease.
-
Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer
A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.
-
Integrated framework to validate and quantify proteoforms in patient-derived ovarian cancer cells
A collaboration will combine advanced top-down proteomics with a new computational method to precisely identify and measure intact proteoforms in tiny samples from ovarian cancer cells.
-
Overcoming platinum resistance in ovarian cancer: finding biomarkers and new targets
Researchers are looking for new biomarkers and targets to help prevent or overcome platinum resistance in high‑risk ovarian cancer so patients have better chances at long-term control.
-
Alternative NF-kB activation after chemotherapy in ovarian cancer
This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.